Patrys Ltd: Appendix 4C - Quarterly - 30 June 2024
Patrys Ltd: Update on GMP manufacturing run of PAT-DX1
Patrys Ltd: Appendix 4C - Quarterly - 31 March 2024
Patrys Ltd: Positive preclinical data for deoxymabs in vasculitis
Patrys Ltd: Change of Director's Interest Notice
Patrys Ltd: Notification of cessation of securities - PAB
Patrys Ltd: Presentation to highlight broader potential of Deoxymabs
Patrys Ltd: Appendix 4D - Half Year Accounts - 31 December 2023
Patrys Ltd: Appendix 4C - Quarterly - 31 December 2023
Patrys Ltd: Change of Director's Interest Notice
Patrys Ltd: GMP Production of PAT-DX1 Next Quarter
Patrys Ltd: Change of Director's Interest Notices x2
Patrys Ltd: Notification of cessation of securities - PAB
Patrys Ltd: Amended Constitution
Patrys Ltd: Results of Annual General Meeting
Patrys Ltd: Chair's Address and CEO Presentation to 2023 AGM
Patrys Ltd: Notification of Expiry of PABOA Listed Options
Patrys Ltd: Patrys Receives R&D Tax Incentive Refund
Patrys Ltd: Appendix 4C - Quarterly - 30 September 2023
Patrys Ltd: Data to be presented at leading brain cancer conference
No Data